| Neurotherapeutics | |
| Cover: | 2013 cover Neurotherapeutics.jpg |
| Editor: | Maral Mouradian |
| Discipline: | Neurology |
| Abbreviation: | Neurotherapeutics |
| Publisher: | Springer Science+Business Media on behalf of the American Society for Experimental NeuroTherapeutics |
| Frequency: | Quarterly |
| History: | 2004-present |
| Impact: | 7.620 |
| Impact-Year: | 2020 |
| Website: | https://www.springer.com/biomed/neuroscience/journal/13311 |
| Link2: | https://link.springer.com/journal/volumesAndIssues/13311 |
| Link2-Name: | Online archive |
| Oclc: | 82448136 |
| Lccn: | 2006215616 |
| Issn: | 1933-7213 |
| Eissn: | 1878-7479 |
Neurotherapeutics is a quarterly peer-reviewed medical journal covering research on experimental treatments of neurological disorders. It was established in 2004 and is published by Springer Science+Business Media on behalf of the American Society for Experimental NeuroTherapeutics. The editor-in-chief is Maral Mouradian (Robert Wood Johnson Medical School). The founding editor-in-chief was Alan I. Faden (University of Maryland School of Medicine).
The journal is abstracted and indexed in:According to the Journal Citation Reports, the journal has a 2020 impact factor of 7.620.[1]